Erratum: Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress (PLOS ONE (2014) 9:8 (e105711) DOI: 10.1371/journal.pone.0105711);Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Han, Zhenying ^a,b   Shen, Fanxia ^a   He, Yue ^a   Degos, Vincent ^a,c   Camus, Marine ^a   Maze, Mervyn ^a   Young, William L ^a,d   Su, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CD11B ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; METHYLLYCACONITINE; NICOTINIC AGENT; PHA 568487; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; DIOXIN; HETEROCYCLIC COMPOUND; NEUROPROTECTIVE AGENT; PHA-568487E;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CD11B GENE; CD206 GENE; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; GENE EXPRESSION; GPX1 GENE; HISTOLOGY; IL 10 GENE; IMMUNOHISTOCHEMISTRY; INOS GENE; MACROPHAGE; MALE; MARKER GENE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOD1 GENE; ANIMAL; C57BL MOUSE; DRUG SCREENING; IMMUNOLOGY; METABOLISM; STROKE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; AZA COMPOUNDS; BRAIN ISCHEMIA; DIOXINS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; MACROPHAGES; MALE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; NICOTINIC AGONISTS; OXIDATIVE STRESS; STROKE;

EID: 84938286834     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152218     Document Type: Erratum

References (38)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127: e6-e245.
2. Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB, et al. (2005) Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 196: 290-297. (Pubitemid 41607817)
3. Lo EH (2009) T time in the brain. Nat Med 15: 844-846.
4. Hayakawa K, Qiu J, Lo EH (2010) Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci 1207: 50-57.
5. Chamorro A, Hallenbeck J (2006) The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37: 291-293. (Pubitemid 43731945)
6. Alberti A, Agnelli G, Caso V, Venti M, Acciarresi M, et al. (2011) Non-neurological complications of acute stroke: frequency and influence on clinical outcome. Intern Emerg Med 6 Suppl 1: 119-123.
7. Emsley HC, Hopkins SJ (2008) Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 7: 341-353. (Pubitemid 351380535)
8. Degos V, Maze M, Vacas S, Hirsch J, Guo Y, et al. (2013) Bone fracture exacerbates murine ischemic cerebral injury. Anesthesiology 118: 1362-1372.
9. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, et al. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci Meth 29: 13435-13444.
10. Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6: 193-201.
11. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, et al. (2012) Comparison of polarization properties of human adult microglia and bloodderived macrophages. Glia 60: 717-727.
12. Hu X, Li P, Guo Y, Wang H, Leak RK, et al. (2012) Microglia/Macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43: 3063-3070.
13. Ulloa L (2005) The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4: 673-684.
14. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462. (Pubitemid 30367422)
15. Su X, Lee JW, Matthay ZA, Mednick G, Uchida T, et al. (2007) Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol 37: 186-192. (Pubitemid 47255001)
16. Duris K, Manaenko A, Suzuki H, Rolland WB, Krafft PR, et al. (2011) alpha7 nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats. Stroke 42: 3530-3536.
17. Lightfoot AP, Kew JN, Skidmore J (2008) Alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators. Prog Med Chem 46: 131-171.
18. Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, et al. (2006) Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology 51: 474-486. (Pubitemid 44215955)
19. Krafft PR, Altay O, Rolland WB, Duris K, Lekic T, et al. (2012) alpha7 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK-3beta inhibition in a mouse model of intracerebral hemorrhage. Stroke 43: 844-850.
20. Su X, Matthay MA, Malik AB (2010) Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol 184: 401-410.
21. Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, et al. (2011) Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol 70: 986-995.
22. Wang Z, Wei X, Liu K, Zhang X, Yang F, et al. (2013) NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke. Free Radic Biol Med 65: 942-951.
23. Kahles T, Brandes RP (2012) NADPH oxidases as therapeutic targets in ischemic stroke. Cell Mol Life Sci 69: 2345-2363.
24. Chen H, Kim GS, Okami N, Narasimhan P, Chan PH (2011) NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiol Dis 42: 341-348.
25. Anrather J, Racchumi G, Iadecola C (2006) NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 281: 5657-5667. (Pubitemid 43847663)
26. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, et al. (2002) A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 117: 207-214. (Pubitemid 34721338)
27. Bouet V, Freret T, Toutain J, Divoux D, Boulouard M, et al. (2007) Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 203: 555-567. (Pubitemid 46157224)
28. Pang L, Ye W, Che XM, Roessler BJ, Betz AL, et al. (2001) Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 32: 544-552. (Pubitemid 32155249)
29. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, et al. (2004) Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 187: 94-104. (Pubitemid 38470016)
30. Langdon KD, Maclellan CL, Corbett D (2010) Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat. J Cereb Blood Flow Metab 30: 1450-1459.
31. Fosbol EL, Folke F, Jacobsen S, Rasmussen JN, Sorensen R, et al. (2010) Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes 3: 395-405.
32. Roumie CL, Mitchel EF, Jr., Kaltenbach L, Arbogast PG, Gideon P, et al. (2008) Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke 39: 2037-2045.
33. Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, et al. (2009) Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Pharmacoepidemiol Drug Saf 18: 1053-1063.
34. Pavlov VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, et al. (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23: 41-45.
35. Cheyuo C, Wu R, Zhou M, Jacob A, Coppa G, et al. (2011) Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 35: 258-265.
36. Shimohama S, Greenwald DL, Shafron DH, Akaika A, Maeda T, et al. (1998) Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. Brain Res 779: 359-363. (Pubitemid 28039980)
37. de Jonge WJ, Ulloa L (2007) The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmac 151: 915-929.
38. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.